Radiation Safety and External Radiation Exposure Rate of Patients Receiving I-131 Therapy for Hyperthyroidism and Remnant Ablation as Outpatient: An Institutional Experience

被引:1
|
作者
Bhatia, Nisha [1 ]
Dhingra, Vandana K. [2 ]
Mittal, Pulkit [1 ]
Saini, Sunil [3 ]
机构
[1] Swami Rama Rama Himalayan Univ SRHU, Canc Res Inst, Dept Nucl Med, Dehra Dun 248016, Uttarakhand, India
[2] All India Inst Med Sci AIIMS, Dept Nucl Med, Rishikesh, Uttarakhand, India
[3] Swami Rama Himalayan Univ, Canc Res Inst, Dept Surg Oncol, Dehra Dun, Uttarakhand, India
关键词
radioiodine therapy; thyrotoxicosis; ablation; outpatient; radiation exposure; RADIOIODINE I-131; CARCINOMA;
D O I
10.1055/s-0043-1771285
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Our objective was to study the radiation exposure rate as function of time in the administration of radioiodine iodine-131 (I-131) for the treatment of thyrotoxicosis or Graves' disease and remnant ablation on an outpatient basis at the Department of Nuclear Medicine, and also, to study the impact of revised discharge criteria for radioiodine therapy enforced by the Atomic Energy Regulatory Board (AERB) of India. Materials and Methods This study included patients who underwent low-dose radioiodine therapy using I-131. Patients were classified into two different groups, that is, group A and group B. Group A included patients receiving low dose I-131 for the treatment of thyrotoxicosis, whereas group B included patients receiving I-131 therapy for the ablation of residual thyroid tissue after total thyroidectomy. The radiation exposure rate was measured using a radiation detector in milli roentgen per hour (mR/h) at 5 cm distance of stomach and neck levels and with the patient standing at the distance of 1 m after oral administration of I-131 at 0, 1, and 2 hours. Results A total of 134 (17 males and 117 females) patients were included in the study. Group A comprised 102 (14 male and 88 females) patients and group B of 32 (3 males and 29 females) patients. At the neck level, the average exposure rate in group A versus group B after 0, 1, and 2 hours was observed to be 6.9 versus 22.27 mR/h, 33.67 versus 43.39 mR/h, and 41.75 versus 48.90 mR/h, respectively. At the stomach level, the exposure rate was 23.65 versus 71.32 mR/h, 13.27 versus 48.45 mR/h, and 9.91 versus 39.43 mR/h after 0, 1, and 2 hours, respectively. At a distance of 1 m, the exposure rate was 1.31 versus 2.99 mR/h, 1.05 versus 2.58 mR/h, and 0.92 versus 2.21 mR/h, respectively. Conclusion Exposure rate measured for patients treated with up to 1,110 MBq (30 mCi) of I-131 was under permissible limits as per revised discharged limits, that
引用
收藏
页码:203 / 207
页数:5
相关论文
共 50 条
  • [1] Study of the External Dose Rate and Retained Body Activity of Patients with Hyperthyroidism Who Are Receiving I-131 Therapy
    Liu Yu Lian
    Zhao Zhi Xin
    Huo Meng Hui
    Yin Chen
    Tan Jian
    Zhang Wen Yi
    Jiao Ling
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2018, 31 (12) : 913 - 916
  • [2] Radiation exposure to caregivers of pediatric neuroblastoma patients undergoing I-131 MIBG therapy
    Markelewicz, Robert
    Lorenzen, William
    Fahey, Frederic
    Treves, S. Ted
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [3] RADIATION-DOSE RATES FROM ADULT PATIENTS RECEIVING I-131 THERAPY FOR THYROTOXICOSIS
    ODOHERTY, MJ
    KETTLE, AG
    EUSTANCE, CNP
    MOUNTFORD, PJ
    COAKLEY, AJ
    NUCLEAR MEDICINE COMMUNICATIONS, 1993, 14 (03) : 160 - 168
  • [4] I-131 THERAPY PATIENTS - RADIATION-DOSE TO STAFF
    CASTRONOVO, FP
    BEH, RA
    VEILLEUX, NM
    RADIATION PROTECTION DOSIMETRY, 1986, 15 (01) : 45 - 49
  • [5] Radiation dose to patients and relatives incident to I-131 therapy
    Zanzonico, PB
    THYROID, 1997, 7 (02) : 199 - 204
  • [6] Quantifying the radiation exposure from patients receiving I131-mIBG therapy
    Kalogianni, E.
    Corcoran, B. J.
    Hooker, C. A.
    D'Sa, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S273 - S273
  • [7] Technologist Radiation Exposure in Routine Clinical Practice with I-131 Administration for Ablation of Thyroid Cancer
    Ergulen, A.
    Ustun, F.
    Yigitbasi, O. N.
    Durmus-Altun, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S826 - S826
  • [8] Radiation safety evaluation for patients with 131I therapy
    Lu Ke-yi
    Li Xian-feng
    Hu Guang
    Liu Jian-zhong
    Li Si-Jin
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [9] Acceptable radiation exposure to contacts of patients treated with low dose radioactive iodine (I-131) post family counseling can pave the way for high dose I-131 therapy on outpatient basis
    Salman, K.
    Yassin, S.
    Munshy, T.
    Almalki, M.
    Zatari, S.
    Khan, Z.
    Elmorsy, S.
    Abdelmoety, D.
    Al-Ezzi, M.
    Al-Otaiby, M.
    Fedah, H.
    Alhazmi, M.
    Ali, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S780 - S780
  • [10] Study of the External Dose Rate and Retained Body Activity of Patients with Hyperthyroidism Who Are Receiving Ⅰ-131 Therapy
    LIU Yu Lian
    ZHAO Zhi Xin
    HUO Meng Hui
    YIN Chen
    TAN Jian
    ZHANG Wen Yi
    JIAO Ling
    Biomedical and Environmental Sciences, 2018, 31 (12) : 913 - 916